Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitrous Oxide for Prevention of Emergence Reaction During Ketamine Administration
NCT02145169Completed
- Sponsor
- Einstein Healthcare Network
- Start
- Oct 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nitrous oxide in delirium, sponsored by Einstein Healthcare Network. Primary endpoint: Emergence Reaction. Started Oct 2013; status: completed.
02
Drugs
nitrous oxide
03
Conditions
delirium
Beyond the preview
Go deeper on NCT02145169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145169.